These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25784151)

  • 1. Bioorthogonal deprotection on the dendritic cell surface for chemical control of antigen cross-presentation.
    Pawlak JB; Gential GP; Ruckwardt TJ; Bremmers JS; Meeuwenoord NJ; Ossendorp FA; Overkleeft HS; Filippov DV; van Kasteren SI
    Angew Chem Int Ed Engl; 2015 May; 54(19):5628-31. PubMed ID: 25784151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.
    Segura E; Villadangos JA
    Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-dressing: an alternative mechanism for antigen presentation.
    Campana S; De Pasquale C; Carrega P; Ferlazzo G; Bonaccorsi I
    Immunol Lett; 2015 Dec; 168(2):349-54. PubMed ID: 26551033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are ERAD components involved in cross-presentation?
    Grotzke JE; Cresswell P
    Mol Immunol; 2015 Dec; 68(2 Pt A):112-5. PubMed ID: 26005101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo.
    van Montfoort N; Mangsbo SM; Camps MG; van Maren WW; Verhaart IE; Waisman A; Drijfhout JW; Melief CJ; Verbeek JS; Ossendorp F
    Eur J Immunol; 2012 Mar; 42(3):598-606. PubMed ID: 22488363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.
    van Montfoort N; Camps MG; Khan S; Filippov DV; Weterings JJ; Griffith JM; Geuze HJ; van Hall T; Verbeek JS; Melief CJ; Ossendorp F
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6730-5. PubMed ID: 19346487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-priming.
    Bevan MJ
    Nat Immunol; 2006 Apr; 7(4):363-5. PubMed ID: 16550200
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-presentation by dendritic cells.
    Joffre OP; Segura E; Savina A; Amigorena S
    Nat Rev Immunol; 2012 Jul; 12(8):557-69. PubMed ID: 22790179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
    Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
    J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells.
    Tran KK; Shen H
    Biomaterials; 2009 Mar; 30(7):1356-62. PubMed ID: 19091401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct antigen presentation by DC shapes the functional CD8(+) T-cell repertoire against the nuclear self-antigen La-SSB.
    Keech CL; Pang KC; McCluskey J; Chen W
    Eur J Immunol; 2010 Feb; 40(2):330-8. PubMed ID: 19950171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation.
    Sei JJ; Haskett S; Kaminsky LW; Lin E; Truckenmiller ME; Bellone CJ; Buller RM; Norbury CC
    PLoS Pathog; 2015 Jun; 11(6):e1004941. PubMed ID: 26107264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting cross-presentation of tumor antigen in human DC.
    Faure F; Mantegazza A; Sadaka C; Sedlik C; Jotereau F; Amigorena S
    Eur J Immunol; 2009 Feb; 39(2):380-90. PubMed ID: 19130478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
    Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
    Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell biology of cross-presentation and the role of dendritic cell subsets.
    Lin ML; Zhan Y; Villadangos JA; Lew AM
    Immunol Cell Biol; 2008; 86(4):353-62. PubMed ID: 18268517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of autophagy in MHC class I-restricted antigen presentation.
    Van Kaer L; Parekh VV; Postoak JL; Wu L
    Mol Immunol; 2019 Sep; 113():2-5. PubMed ID: 29126597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.